Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction

Lung Cancer

Volumn 48, Issue 1, 2005, Pages 77-83

  Sueoka, Eisaburo ^a   Sueoka, Naoko ^a   Iwanaga, Kentaro ^a   Sato, Akemi ^a   Suga, Kenji ^a   Hayashi, Shin Ichiro ^a   Nagasawa, Kohei ^a   Nakachi, Kei ^b  

^a SAGA UNIVERSITY   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

Biomarker; Early detection; hnRNP B1; Plasma mRNA; Real time PCR

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; MESSENGER RNA; RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG DISEASE; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SQUAMOUS CELL CARCINOMA; VOLUNTEER;

EID: 15044356588     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.10.007     Document Type: Article

References (21)

1. The Editorial Board of Cancer Statistics in Japan. Mortality from malignant neoplasms by age group and sex in Japan. In: Kakizoe T, Yamaguchi N, Mitsuhashi F, Koshiji M, Oshima A, Ohtaka M, editors. Cancer statistics in Japan. Tokyo: Foundation for Promotion of Cancer Research; 2001.
2. Lung Cancer Registration Committee. Time trends and survival rate of lung cancer. In: Watanebe S, Tominaga W, Kakizoe T, editors. Gann monograph on cancer research 43. Tokyo: Japan Scientific Societies Press; 1995. p. 119-27
3. Hirsch FR, Bunn PA Jr, Dmitrovsky E, Field JK, Franklin WA, Greenberg RE, et al. Proceedings of the IV International Conference on Prevention and Early Detection of Lung Cancer, Reykjavik, Iceland, 9-12 August 2001. Lung Cancer 2002;37:325-44.
4. C.G. Burd, and G. Dreyfuss Conserved structures and diversity of functions of RNA-binding proteins Science 265 1994 615 621
5. A. Mayeda, S.H. Munroe, J.F. Caceres, and A.R. Krainer Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins EMBO J 13 1994 5483 5495
6. M.S. Tockman, P.K. Gupta, and J.D. Myers Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection J Clin Oncol 6 1988 1685 1693
7. J. Zhou, J.L. Mulshine, E.J. Unsworth, F.M. Scott, I.M. Avis, and M.D. Vos Purification and characterization of a protein that permits early detection of lung cancer J Biol Chem 18 1996 10760 10766
8. E. Sueoka, N. Sueoka, and Y. Goto Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia Cancer Res 61 2001 1896 1902
9. M. Tominaga, N. Sueoka, K. Irie, K. Iwanaga, O. Tokunaga, and S. Hayashi Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67 Lung Cancer 40 2003 45 53
10. S. Wu, M. Sato, C. Endo, A. Sakurada, B. Dong, and H. Aikawa hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung Lung Cancer 41 2003 179 186
11. Y. Goto, E. Sueoka, H. Chiba, and H. Fujiki Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma Jpn J Cancer Res 90 1999 1358 1363
12. S. Matsuyama, Y. Goto, and N. Sueoka Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinoma as a new biomarker for diagnosis Jpn J Cancer Res 91 2000 658 663
13. M. Stroun, P. Anker, M. Beljanski, J. Henri, C. Lederrey, and M. Ojha Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture Cancer Res 38 1978 3546 3554
14. A.J. Wieczorek, C. Rhyner, and L.H. Block Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc Natl Acad Sci USA 82 1985 3455 3459
15. M.S. Kopreski, F.A. Benko, L.W. Kwak, and C.D. Gocke Detection of tumor messenger RNA in the serum of patients with malignant melanoma Clin Cancer Res 5 1999 1961 1965
16. X.Q. Chen, H. Bonnefoi, M.F. Pelte, J. Lyautey, C. Lederrey, and S. Movarekhi Telomerase RNA as a detection marker in the serum of breast cancer patients Clin Cancer Res 6 2000 3823 3826
17. M. Fleischhacker, T. Beinert, M. Ermitsch, D. Seferi, K. Possinger, and C. Engelmann Detection of amplifiable messenger RNA in the serum of patients with lung cancer Ann N Y Acad Sci 945 2001 179 188
18. M.S. Kopreski, F.A. Benko, and C.D. Gocke Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum Ann N Y Acad Sci 945 2001 172 178
19. S. Gal, C. Fidler, Y.M. Lo, K. Chin, J. Moore, and A.L. Harris Detection of mammaglobin mRNA in the plasma of breast cancer patients Ann N Y Acad Sci 945 2001 192 194
20. J. Silva, J.M. Silva, V. Garcia, J.M. Garcia, G. Dominguez, and F. Bonilla RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma Genes Chromosomes Cancer 35 2002 375 3756
21. H. Tani, K. Ohshima, S. Haraoka, M. Hamasaki, H. Kamma, and S. Ikeda Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin Int J Oncol 21 2002 957 963